The staff of the center took part in the scientific and educational seminar "Eosinophil. The unknown Universe". Within the framework of the interactive session, the possibilities of biological therapy of severe bronchial asthma were discussed and clinical cases were analyzed.
Our Site was ranked the 3rd place in terms of recruitment in the world in the Vivid-1 (AMAM) study. Russia is in the top 5! We thank the team for their excellent work!
Our Study Site is open to recruiting patients for a phase III clinical trial in order to evaluate the efficacy and safety of a new oral medicine for patients with moderate or severe Crohn's disease, sponsored by the pharmaceutical company Selgene, Switzerland.
A new visit to the opening of the center: GALACTIC-1 phase IIb clinical trial involving patients with Idiopathic Pulmonary Fibrosis, sponsored by the pharmaceutical company Galecto Bayotek AB, Denmark
